COPD patient with DreamWear

COPD patient with DreamWear
Asset published on May 22, 2018
Select your preferred file


Economic analysis of Philips-sponsored study shows cost savings of more than $3,900 per patient in the United States by combining non-invasive ventilation with home oxygen therapy.

You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.